Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial
References Novo Nordisk India partners with Emcure Pharma to commercialize Poviztra in India as a second brand of Wegovy, Emcure, 10 November 2025, available at Anti-obesity segment sees heavy-weights Novo Nordisk and Eli Lilly slug it out, Businessline, 10 November 2025, Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India, The Economic Times, 10 November 2025, Mounjaro Now Ciplas Yurpeak: A New Chapter for Tirzepatide in India, 24 October 2025, Pharmacally, Long-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyond Weight Loss, 26 October 2025, Pharmacally, Semaglutide Battle Latest Court Ruling Explained, Dr
You can find many of these herbs in our Digest Support
It increases insulin secretion, decreases glucagon (which raises blood sugar), and slows digestion, resulting in improved glycemic control and reduced hunger